Edwards Lifesciences Corporation
EW
Ранг среди акций
#489
Edwards Lifesciences Corporation is a global medical technology firm... Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.
Цена акции
$86.46
Последняя синхронизация: 2026-10-16
Рыночная капитализация
$49.82B
Изменение (1 день)
-1.75%
Изменение (1 год)
15.84%
Страна
US
Торговля Edwards Lifesciences Corporation (EW)
Категория
Healthcare
Операционная маржа для Edwards Lifesciences Corporation (EW)
Операционная маржа на October 2026 TTM: 28.09%
Согласно последним финансовым отчетам и цене акций Edwards Lifesciences Corporation, текущая операционная маржа (TTM) составляет 28.09%. В конце 2024 она составила 25.35%.
История операционной маржи Edwards Lifesciences Corporation с 2000 по 2026
Операционная маржа на конец каждого года
| Год | Операционная маржа | Изменить |
|---|---|---|
| 2026 (TTM) | 28.09% | -2,630.63% |
| 2025 | -1.11% | -104.38% |
| 2024 | 25.35% | -11.02% |
| 2023 | 28.49% | -9.93% |
| 2022 | 31.63% | 2.76% |
| 2021 | 30.78% | 4.16% |
| 2020 | 29.55% | 7.26% |
| 2019 | 27.55% | -6.10% |
| 2018 | 29.34% | -0.20% |
| 2017 | 29.40% | 6.83% |
| 2016 | 27.52% | 19.19% |
| 2015 | 23.09% | 10.11% |
| 2014 | 20.97% | -0.94% |
| 2013 | 21.17% | 1.39% |
| 2012 | 20.88% | 6.48% |
| 2011 | 19.61% | 0.46% |
| 2010 | 19.52% | 10.72% |
| 2009 | 17.63% | 4.38% |
| 2008 | 16.89% | 8.76% |
| 2007 | 15.53% | -1.52% |
| 2006 | 15.77% | -10.40% |
| 2005 | 17.60% | 6.15% |
| 2004 | 16.58% | 3.11% |
| 2003 | 16.08% | 117.30% |
| 2002 | 7.40% | 113.26% |
| 2001 | 3.47% | -70.64% |
| 2000 | 11.82% | 0.00% |
Операционная маржа для аналогичных компаний или конкурентов
| Компания | Операционная маржа | Разница в операционной марже | Страна |
|---|---|---|---|
| 17.03% | -99.39% |
US
|
|
| 17.86% | -99.36% |
IE
|
|
| 22.03% | -99.22% |
US
|
|
| 21.46% | -99.24% |
US
|
|
| 0.00% | - |
DE
|
Что такое операционная маржа компании?
Операционная маржа — это ключевой показатель прибыльности компании. Более высокая операционная маржа обычно означает, что компания может продавать свои товары или услуги значительно дороже их себестоимости. Она рассчитывается путем деления прибыли компании на её выручку.